<table>
<thead>
<tr>
<th><b>Model: Baseline characteristics</b></th>
<th><b>Descriptive
statistics</b></th>
<th><b>Full model</b></th>
<th><b>Full model</b></th>
<th><b>Univariate model</b></th>
<th><b>Univariate model</b></th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td></td>
<td><b>Exponentiated β (95% CI)</b></td>
<td>
<i>P</i><b> value</b>
</td>
<td><b>Exponentiated β (95% CI)</b></td>
<td>
<i>P</i><b>
value</b>
</td>
</tr>
<tr>
<td>Not motivated for medicine changes (ref. Motivated for medicine
changes), No. (%)</td>
<td>39 (19.9%)</td>
<td>0.74 (0.59 to 0.92)</td>
<td>.009</td>
<td>0.72
(0.55 to 0.93)</td>
<td>.016</td>
</tr>
<tr>
<td>Referred from the geriatric department (ref. Referred from GP), No. (%)</td>
<td>59 (30.1%)</td>
<td>0.75 (0.58 to 0.96)</td>
<td>.024</td>
<td>0.78 (0.63 to 0.97)</td>
<td>.026</td>
</tr>
<tr>
<td>Age in years (continuous), median (IQR)</td>
<td>80 (74 to 85 )</td>
<td>1.02 (1.00 to
1.03)</td>
<td>0.009</td>
<td>1.003 (0.99 to 1.02)</td>
<td>.63</td>
</tr>
<tr>
<td>No. of medicines at baseline, median (IQR)</td>
<td>12 (10 to 14)</td>
<td>1.08 (1.05
to 1.11)</td>
<td>&lt; .001</td>
<td>1.09 (1.07 to 1.12)</td>
<td>&lt;
.001</td>
</tr>
<tr>
<td>Drug Burden Index, median (IQR)</td>
<td>0.5 (0 to 1)</td>
<td>1.15 (1.03 to 1.29)</td>
<td>.015</td>
<td>1.26 (1.13 to 1.40)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td><b>Model: Medicine groups</b></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>(ref. Medicine group not used), No. (%)</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Propulsives</td>
<td>15 (7.7%)</td>
<td>1.42 (1.02 to 1.97)</td>
<td>.038</td>
<td>1.73 (1.30 to
2.26)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Metoclopramid</td>
<td>15</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Iron bivalent, oral preparations</td>
<td>28 (14.3%)</td>
<td>1.51 (1.14 to 2.01)</td>
<td>.005</td>
<td>1.40 (1.07 to 1.80)</td>
<td>.013</td>
</tr>
<tr>
<td>Ferrous fumarate</td>
<td>16</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Ferrous sulphate</td>
<td>11</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Ferrous tartrate</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Other antidepressants</td>
<td>26 (13.3%)</td>
<td>1.52 (1.13 to 2.04)</td>
<td>.006</td>
<td>1.66
(1.29 to 2.11)</td>
<td>&lt; .001</td>
</tr>
<tr>
<td>Mirtazapin</td>
<td>14</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Venlafaxin</td>
<td>5</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Duloxetin</td>
<td>4</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Mianserin</td>
<td>2</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Agomelatin</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Propionic acid derivatives</td>
<td>19 (9.7%)</td>
<td>1.54 (1.14 to 2.07)</td>
<td>.005</td>
<td>1.47 (1.11 to 1.91)</td>
<td>.006</td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>18</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Dexibuprofen</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Drugs for urinary frequency and incontinence</td>
<td>14 (7.1%)</td>
<td>1.97 (1.37
to 2.79)</td>
<td>&lt;.001</td>
<td>1.36 (0.95 to 1.87)</td>
<td>.076</td>
</tr>
<tr>
<td>Mirabegron</td>
<td>8</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Tolterodine</td>
<td>4</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Solifenacin</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Trospium</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>